How CO2 helps
Transdermal carbon dioxide therapy can support the healing of soft body tissue injuries, directly decrease inflammation and pain, act as an anti-oxidant to preserve tissue, and decrease the survival of hypoxic cancer cells. Scroll down for additional information, or read more details in our FAQ.
Photos and videos from before and after treatment.
Effective, SaFe, NONINVASIVE, PAINLESS, EASY TO USE, PORTABLe
The Power of Transdermal Therapy
Laboratory studies in cells, animals and humans clearly demonstrate that carbon dioxide has many potential mechanisms for treating a variety of diseases.
Transdermal pharmaceutical carbon dioxide dramatically increases tissue blood flow and oxygenation. It also decreases concentration of HIF1 alpha and it directly decreases the main biological compound that regulates inflammation (NFkB). And, transdermal carbon dioxide has a powerful role in reducing the reactive oxygen species (ROS) thus ameliorating the ROS activity.
Additional biological benefits of pharmaceutical carbon dioxide
Increased nitric oxide thus enhancing flow dependent dilation
Increased mitochondrial biogenesis
Promotion of VEGF upregulation
Neovascularization and capillary growth
Activation of myogenesis thus accelerating muscle injury repair over fibrosis
Suppression of the growth of metastic squamous cells and osteosarcoma
Clinical research has shown positive effects of transcutaneous pharmaceutical carbon dioxide in treating peripheral vascular disease, exercise endurance, skin grafts, wound healing, muscle disuse, tumorigenesis, and bone fractures. In addition, there is every reason to predict positive effects for laminitis; although, it has not yet been tested.